Bibliography

  • Bruno Horisberger
  • Rolf Dinkel
Part of the Health Systems Research book series (HEALTH)

Keywords

Toxicity Mold Anemia Marketing Stein 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

General Risk Topics

  1. Anonymous (1987) Acceptable degrees of therapeutic risks. Scrip 24 June: 22Google Scholar
  2. Aronow WS et al. (1987) Risk factors for atherothrombotic brain infarction in persons over 62 years of age in a long-term health care facility. Am Geriatr Soc 35: 1–3Google Scholar
  3. Bajgier SM (1982) An interactive model of attitude and risk-benefit formation regarding social issues. Policy Sci 14: 257–278CrossRefGoogle Scholar
  4. Berando FM (1986) Survivor education: the role of habits, attitudes and risk taking. Death Stud 10: 391–409CrossRefGoogle Scholar
  5. Blomquist G (1986) A utility maximization model of driver traffic safety behavior. Accid Anal Prev 18: 371–375PubMedCrossRefGoogle Scholar
  6. Brauers WK (1986) Essay review article: risk, uncertainty and risk analysis. Long Range Plan 19: 139–143CrossRefGoogle Scholar
  7. Breyer F, Fuchs VR (1982) Risk attitudes in health: an exploratory study. National Bureau of Economic Research, Working Paper 857Google Scholar
  8. British Medical Association Guide (1987) Living with risk. Wiley, ChichesterGoogle Scholar
  9. Bühlmann H, Loeffel H, Nievergelt E (1969) Einführung in die Theorie und Praxis der Entscheidung bei Unsicherheit. 2nd edn Springer, Berlin Heidelberg New YorkGoogle Scholar
  10. Carpenter PF (1982) Risk assessment. Meeting on risk assessment, National Academy of Science, 10 FebGoogle Scholar
  11. Chelemer MJ (1987) The hazardous substances initiative: working to create safer tomorrow. MIT Report May: 4 - 7Google Scholar
  12. Covello VT (1987) Decision analysis and risk management decision making: issues and methods. Risk Anal 7: 131–139PubMedCrossRefGoogle Scholar
  13. Covello VT, et al. (1982) Risk analysis, philosophy and the social and behavioral sciences. Risk Anal 2: 53–58CrossRefGoogle Scholar
  14. Covello VT, Mumpower J (1985) Risk analysis and risk management: an historical perspective. Risk Anal 5: 103–120CrossRefGoogle Scholar
  15. European Community (1980) Nuclear and non-nuclear risk - an exercise in comparability. Final Report, EUR 6417 EN. Pollution Prevention (Consultants), Crawley, UKGoogle Scholar
  16. Fischhoff B, Lichtenstein S, Slovic P et al. (1981) Acceptable risk. Cambridge University PressGoogle Scholar
  17. Fritzsche AF (1986) Wie sicher leben wir? Risikobeurteilung und Bewältigung in unserer Gesellschaft. TÜV Rheinland, CologneGoogle Scholar
  18. Goodman J (1986) On criteria of insignificant difference between two risks. Risk Anal 6: 235–244CrossRefGoogle Scholar
  19. Haight FA (1986) Risk, especially risk of traffic accident. Accid Anal Prev 18: 359–366PubMedCrossRefGoogle Scholar
  20. Hanley JW (1981) Monsanto’s early warning system. Harvard Bus Rev Nov/Dec: 107–122Google Scholar
  21. Helal B (1984) Physical risks in modern sport. Med Sci Law 24: 247–248PubMedGoogle Scholar
  22. Hollaender A (1986) Acceptance of the distinguished contribution award of the society for risk analysis. Risk Anal 6: 113–115PubMedCrossRefGoogle Scholar
  23. Imhof AE (1981) Die gewonnenen Jahre. Von der Zunahme unserer Lebensspanne seit dreihundert Jahren oder von der Notwendigkeit einer neuen Einstellung zu Leben und Sterben. Beck, MunichGoogle Scholar
  24. Johnson BB, Covello VT (eds) (1987) The social and cultural construction of risk: essays on risk selection and perception. Reidel, BostonGoogle Scholar
  25. Kuhlmann A (1981) Einführung in die Sicherheitswissenschaft. Vieweg, TÜV Rheinland, CologneGoogle Scholar
  26. Kunreuther H et al. (1984) A decision-process perspective on risk and policy analysis. Manage Sci 30: 475–485CrossRefGoogle Scholar
  27. Lave LB (1987) Health and safety risk analysis. Science 236: 291–295PubMedCrossRefGoogle Scholar
  28. Lowrance WW (1976) Of acceptable risk. Kaufmann, CaliforniaGoogle Scholar
  29. Lowrance WW (1986) The ethics of access to health care. Bridge 16: 14–18Google Scholar
  30. Lund AK et al. (1986) Perceived risks and driving behavior. Accid Anal Prev 18: 367–370PubMedCrossRefGoogle Scholar
  31. Meadows D (1972) Die Grenzen des Wachstums. Bericht des “Club of Rome” zur Lage der Menschheit. Deutsche Verlags-Anstalt, StuttgartGoogle Scholar
  32. Medawar C (1986) No news, good news? Scrip 1162: 18–19Google Scholar
  33. Medawar C (1987) Failings of the pharmaceutical industry. Pharmaceut Med 2: 259–263Google Scholar
  34. Miller SA (1984) Introductory remarks to session on risk assessment and risk management. Fundam Appl Toxicol 4: 380–382CrossRefGoogle Scholar
  35. National Research Council (1982) Risk and decision making: perspectives and research. National Academy Press, Washington D.C.Google Scholar
  36. National Research Council (1983) Risk assessment in the federal government: managing the process. National Academy Press, Washington D.C.Google Scholar
  37. Nelkin D (1987) The culture of science journalism. Society Sept-Oct: 18–25Google Scholar
  38. Orleans M, Haverkamp AD (1987) Are there health risks in using risking systems? The case of perinatal risk assessment. Health Policy 7: 297–307PubMedCrossRefGoogle Scholar
  39. Peets JI et al. (1987) The assessment of major hazards: the density and other characteristics of the exposed population around a hazard source. J Hazard Mater 14: 337–363CrossRefGoogle Scholar
  40. Rosen S (1981) Valuing health risk. AEA Papers Proc: 241–245Google Scholar
  41. Rothschild L (1987) Risk. Listener 30 NovGoogle Scholar
  42. Royal Society Study Group (1983) Risk assessment. Royal Society, LondonGoogle Scholar
  43. Ruckelhaus WD (1983) Science, risk and public policy. Science 221: 1026–1028CrossRefGoogle Scholar
  44. Ruckelhaus WD (1984) Risk in a free society. Vital Speeches Day 1: 354–358Google Scholar
  45. Schneider T (1981) Grundgedanken und Methodik moderner Sicherheitsplanung. Sicherheitsingenieur 8: 26–30 /9: 18–29Google Scholar
  46. Starr C et al. (1980) Risks of risk decisions. Science 208: 1114–1119PubMedCrossRefGoogle Scholar
  47. Swedish Drug Information Council (1987) The elderly and medicines. Swedish Drug Information Council, StockholmGoogle Scholar
  48. Teeling-Smith G (1983) Measuring the social benefits of medicine. Office of Health Economics, LondonGoogle Scholar
  49. Tenner E (1987) Warning: nature may be hazardous to your health. Harvard Magazine Sept-Oct: 34–38Google Scholar
  50. von Winterfeldt D, Edwards W (1984) Patterns of conflict about risky technologies. Risk Anal 4: 555–568CrossRefGoogle Scholar
  51. Wilde GJS (1987) Theorie der Risikokompensation der Unfallverursachung und praktische Folgerungen für die Unfallverhütung. Unfallheilkunde 130: 134–156Google Scholar
  52. Wilson R, Crouch EAC (1987) Risk assessment and comparisons: an introduction. Science 236: 267–270PubMedCrossRefGoogle Scholar
  53. Wittmann W (1982) Risikobewältigung: Gratwanderung zwischen Sicherheit und Freiheit. Informationstagung der SVA. In: Neue Zürcher Zeitung, Zeitfragen: 289 (11/12 Dec 1982 )Google Scholar
  54. Wynne B (1983) Technologie, Risiko und Partizipation: zum gesellschaftlichen Umgang mit Unsicherheit. In: Conrad J (ed) Gesellschaft, Technik und Risikopolitik. Springer, Berlin Heidelberg New YorkGoogle Scholar
  55. Yadigaroglu G, Chakraborty S (eds) (1985) Risikountersuchungen als Entscheidungsinstrument. TÜV Rheinland, CologneGoogle Scholar
  56. Young FE (1987) Risk assessment: the convergence of science and the law. Regul Toxicol Pharmacol 7: 179–184PubMedCrossRefGoogle Scholar

Risk Perception

  1. Batelle-Institut (1981) Untersuchungen über die technischen, organisatorischen und gesellschaftlichen Voraussetzungen für Risikostrategien im Bereich technologischer Entwicklung (Endbericht) RS 1/2-510321, SR 70. Batelle, FrankfurtGoogle Scholar
  2. Borman SA (1983) Origin of risk assessment. Anal Chem 55: 1438a–1440aPubMedCrossRefGoogle Scholar
  3. Brown J (1987) Risk perception: expert opinion versus public understanding. ESRC Newslett 59: 17–19Google Scholar
  4. Carpenter PF (1983) Understanding risk. Med Device Diagn Industry 5 (6): 24–26Google Scholar
  5. Drabek TE (1986) Human system response to disaster: an inventory of sociological findings. Springer, New York Berl in HeidelbergCrossRefGoogle Scholar
  6. Fishburn PC (1984) Foundations of risk measurement. Manage Sci 30: 396–406CrossRefGoogle Scholar
  7. Gafni A et al. (1984) Risk attitude and time preference in health. Manage Sci 30: 440–451CrossRefGoogle Scholar
  8. Heilmann K, Urquhart J (1983) Keine Angst vor der Angst. Risiko - Element unseres Lebens und Motor des Fortschritts. Kindler, MunichGoogle Scholar
  9. Jung CG (1975) Über die Psychologie des Unbewußten. Fischer, Frankfurt/M.Google Scholar
  10. Kishchuk NA (1987) Causes and correlates of risk perception. Risk Abstr 4: 1–4Google Scholar
  11. Kietz TA (1983) The mathematics of risk. Interdisciplinary Sci Rev 8: 114–119Google Scholar
  12. Kuhlmann A (1978) Sicherheit als Wert in Technik und Gesellschaft. In: Ropohl G et al. Maßstäbe der Technikbewertung. Vorträge und Diskussionen, VDI Tagung, 18 and 19 Nov 1977. VDI Prints, DüsseldorfGoogle Scholar
  13. Lave LB, Menkes J (1985) Managing risk: a joint US-German perspective. Risk Anal 5: 11–23CrossRefGoogle Scholar
  14. Lee TR (1981) The public perception of risk and the question of irrationality. Proc R Soc Lond 376 a: 5–16CrossRefGoogle Scholar
  15. Lerch I (1980) Risk and fear. New Sci Jan: 8–11Google Scholar
  16. Lowrance WW (1983) The agenda for risk decision making. Environment 25 (10): 4–8CrossRefGoogle Scholar
  17. Lowrance WW (1985) Modern science and human values. Oxford University Press, New YorkGoogle Scholar
  18. O’Donnell M (1986) The media and their influence on public attitudes to drug development and use. Br J Clin Pharmacol 22: 101s–102sPubMedGoogle Scholar
  19. Otway H, Thomas K (1982) Reflections on risk perception and policy. Risk Anal 2: 69–82CrossRefGoogle Scholar
  20. Pochin EE (1975) The acceptance of risk. Br Med Bull 31: 184–189PubMedGoogle Scholar
  21. Schneider SL, Lopes LL (1986) Reflection in preferences under risk: who and when may suggest why. J Exp Psychol 12: 535–548CrossRefGoogle Scholar
  22. Slovic P (1987) Perception of risk. Science 236: 286–290CrossRefGoogle Scholar
  23. Slovic P et al. (1984) Modeling the societal impact of fatal accidents. Manage Sci 30: 464–474CrossRefGoogle Scholar
  24. Slovic P et al. (1987) Risk perception and risk regulation. Administrative Conference of the U.S., Washington D.C., 5 MarchGoogle Scholar
  25. Starr C (1985) Risk management, assessment, and acceptability. Risk Anal 5: 97–102CrossRefGoogle Scholar
  26. Starr C et al. (1984) A perspective on health and safety risk analysis. Manage Sci 30: 452–463CrossRefGoogle Scholar
  27. von Wartburg WP (1984) Drugs and the perception of risk. Swiss Pharma 6 (11a): 21–23Google Scholar
  28. Wildavsky A (1984) Die Suche nach einer fehlerlosen Risikominderungsstrategie. In: Lange S (ed) Ermittlung und Bewertung industrieller Risiken. Springer, Berlin Heidelberg New YorkGoogle Scholar

Risk Communication

  1. Anonymus (1987) NRC launches study on risk communication. Risk Newslett June: 13–14Google Scholar
  2. Brushwood DB, Simonsmeier LM (1986) Drug information for patients - duties of the manufacturer, pharmacist, physician and hospital. J Leg Med 7: 279–340PubMedCrossRefGoogle Scholar
  3. Davies JC, Covello VT, Allen FW (eds) (1987) Risk communication. Conservation Foundation, Washington D.C.Google Scholar
  4. Kasperson RE (1986) Six propositions on public participation and their relevance for risk communication. Risk Anal 6: 275–281PubMedCrossRefGoogle Scholar
  5. Keeney RL, von Winterfeldt D (1986) Improving risk communication. Risk Anal 6: 417–424PubMedCrossRefGoogle Scholar
  6. Röglin HC (1984) Kommunikationsrisiken der Großtechnologien. In: Lange S (ed) Ermittlung und Bewertung industrieller Risiken. Springer, Berlin Heidelberg NewGoogle Scholar
  7. Shapiro S (1985) The decision to publish ethical dilemmas. J Chron Dis 38: 365–372CrossRefGoogle Scholar
  8. Sharlin HI (1986) EDB: a case study in communicating risk. Risk Anal 6: 61–68PubMedCrossRefGoogle Scholar

Regulation

  1. Albert RE (1985) Risk assessment in regulatory decision-making in the EPA. In: Homburger (ed) Safety evaluation and regulation of chemicals 2. Karger, Basel, pp 146–149Google Scholar
  2. Beauchamp TL (1978) The regulation of hazards and hazardous behaviors. Health Educ Monogr 6: 242–257PubMedCrossRefGoogle Scholar
  3. Bogen KT (1983) Quantitative risk-benefit analysis in regulatory decision-making. J Health Politics Policy Law 8: 120–140CrossRefGoogle Scholar
  4. Carpenter PF (1987) Medical device regulation and product liability: responsibility, risk and informed consent. NAE/IOM Symposium, 9 March, in pressGoogle Scholar
  5. Huber P (1985) Safety and the second best: the hazards of public risk management in the courts. Columbia Law Rev 85: 277–337CrossRefGoogle Scholar
  6. Mattison N (1984) Regulatory scene. Pharmaceut Med 1: 13–16Google Scholar
  7. Montesano R, Tomatis L (1977) Legislation concerning chemical carcinogens in several industrialized countries. Cancer Res 37: 310–316PubMedGoogle Scholar
  8. Petak WJ, Atkisson AA (1982) Natural hazard risk assessment and public policy. Springer, New York Berlin HeidelbergCrossRefGoogle Scholar
  9. Pfund P (1982) Recht und Risiko. Tagung 22–23 Nov, Zürich-Oerlikon, Referat 12. Schweiz. Vereinigung für Atomenergie, BernGoogle Scholar
  10. Roth DH, Wyzga RE, Hammerstrom T (1984) The use of risk assessment in developing health-based regulations. ASTM Spec Techn Publ 845: 46–65Google Scholar
  11. Scheuplein RJ (1987) Risk assessment and food safety: a scientist’s and regulator’s view. Food Drug Cosm Law J 42: 237–250Google Scholar
  12. Schroeder CH (1986) Rights against risks. Columbia Law Rev 86: 495–562CrossRefGoogle Scholar
  13. Silverglade BA (1983) The risks of risk assessment and risk-benefit analysis. Food Drug Cosm Law J 38: 318–324Google Scholar
  14. Smith MV (1984) Use of risk assessment in regulatory decision-making. Food Technol Oct: 114–118Google Scholar
  15. Taylor MR (1984) The role of law in risk management. Fundam Appl Toxicol 4: 408–417CrossRefGoogle Scholar
  16. Travis CC, Richter SA et al. (1987) Risk and regulation. Chem Tech Aug: 478–483Google Scholar
  17. van Andel FG (1985) On regulating perceived risk. Effective Health Care 2: 231–237PubMedGoogle Scholar

Industrial Risks

  1. Anonymous (1986) Accidents will happen. Economist 10 May: 13–14Google Scholar
  2. Anonymous (1987) Unkalkulierbares Risiko. Wirtschaftswoche 13 March: 36–62Google Scholar
  3. Baxter PJ (1986) From Flyxborough to Bhopal: is legislation enough? Br J Industr Med 43: 1–3Google Scholar
  4. Bohnenblust H (1985) Die Anwendung eines risikoorientierten Sicherheitsmodells zur Beurteilung der Neubaustreckentunnel der Deutschen Bundesbahn. In: Yadigaroglu G, Chakraborty S (eds) Risikountersuchungen als Entscheidungsinstrument. TÜV Rheinland, Cologne, pp 431–361Google Scholar
  5. Hartwig S (ed) (1983) Grosse, technische Gefahrenpotentiale, Risikoanalysen und Sicherheitsfragen. Springer, Berlin Heidelberg New YorkGoogle Scholar
  6. Kates RW, Kasperson JX (1983) Comparative risk analysis of technological hazards. Proc Natl Acad Sci USA Nov: 7027–7038Google Scholar
  7. Lagedec P (1982) Major technological risk: an assessment of industrial disasters. Pergamon, New YorkGoogle Scholar
  8. Lange S (ed) (1984) Ermittlung und Bewertung industrieller Risiken. Springer, Berlin Heidelberg New YorkGoogle Scholar
  9. Moolenaar RJ (1986) The industrial role in risk assessment. Sci Total Environ 51: 75–80PubMedCrossRefGoogle Scholar
  10. Schön G (1982) Grundlagen der Erfassung und Bewertung technischer Risiken. In: VDE/VDI- Tagung: Risiko - Schnittstelle zwischen Recht und Technik. VDE, Berlin, pp 45–62Google Scholar
  11. Sellner D (1982) Die Bewertung technischer Risiken bei der Rechtsanwendung. In: VDE/VDI-Tagung: Risiko - Schnittstelle zwischen Recht und Technik. VDE, Berlin, pp 183–203Google Scholar
  12. Zerna W (1983) Grundlagen der gegenwärtigen Sicherheitspraxis in der Bautechnik. In: Hartwig S (ed) Grosse technische Gefahrenpotentiale, Risikoanalysen und Sicherheitsfragen. Springer, Berlin Heidelberg New YorkGoogle Scholar

Nuclear Risks

  1. Dumenil G (1977) Energie nucléaire et opinion publique. Report 2. ADISH/IREP, Paris, GrenobleGoogle Scholar
  2. Fritz-Niggli H (1983) Problematik von Risikoschätzungen - Beispiel kleine Strahlendosen. Referat an der SVA/OeAF Informationstagung: Sicherheits- und Risikodenken im Zeitalter der Kernenergie, Zürich-Oerlikon, 22–23 Nov 1982. In: Neue Zürcher Zeitung, Beilage Forschung und Technik 75, 30 MarchGoogle Scholar
  3. Fritz-Niggli H (1983) Gefahren der Radioaktivität. Neue Zürcher Zeitung, Zeitfragen: 24, 30 (29/30 Jan, 5/6 Feb)Google Scholar
  4. Fritzsche AF, de Haller G, Nahm W (1982) Die Sicherheit der nuklearen Energieerzeugung: Berichte der SNG zur Kernenergie, Bd 5. SNG, BernGoogle Scholar
  5. GRS (1979) Deutsche Risikostudie Kernkraftwerke. Eine Untersuchung zu dem durch Störfälle in Kernkraftwerken verursachten Risiko, Hauptband. TUV Rheinland, CologneGoogle Scholar
  6. Nowotny H (1979) Kernenergie: Gefahr oder Notwendigkeit. Suhrkamp, FrankfurtGoogle Scholar
  7. Okrent D (1987) The safety goals of the U.S. Nuclear Regulatory Commission. Science 236: 296–300PubMedCrossRefGoogle Scholar
  8. Société Française de Radioprotection (1977) Colloque sur les implications psycho-sociologiques du développement de l’industrie nucléaire, 13–15 Jan, ParisGoogle Scholar
  9. Wallace MD, Crissey BL, Sennott LI (1986) Accidental war: risk assessment. J Peace Res 23: 9–27CrossRefGoogle Scholar

Environmental Risks

  1. Anderson HA (1985) Evolution of environmental epidemiologic risk assessment. Environ Health, Perspectives 62: 389–392CrossRefGoogle Scholar
  2. Baird BNR (1986) Tolerance for environmental health risks: the influence of knowledge, benefits, voluntariness, and environmental attitudes. Risk Anal 6: 425–435PubMedCrossRefGoogle Scholar
  3. Conrad J (1986) Nitrates in ground and drinking water: analysis of policies and regulations. Sci Total Environ 51: 209–225PubMedCrossRefGoogle Scholar
  4. Daetwyler JJ (1978) Das Erdbebenrisiko in der Schweiz, neue Erdbebenrisikokarten für die Schweiz fertiggestellt. Neue Zürcher Zeitung, Beilage Nr. 175: Forschung und Technik, 14 JuneGoogle Scholar
  5. Eichler W (1982) Gift in unserer Nahrung. Die Brisanz der Umweltgifte in Nahrungsketten. Kilda, GrevenGoogle Scholar
  6. Environmental Protection Agency (1986) EPA to publish guidelines for risk assessment. Environ News 25 AugGoogle Scholar
  7. Froines JR et al. (1986) Occupational health surveillance: a means to identify work-related risks. Am J Public Health 76: 1089–1096PubMedCrossRefGoogle Scholar
  8. Hattis D, Kennedy D (1986) Assessing risks from health hazards: an imperfect science. Technol Rev May/June: 60–71Google Scholar
  9. Hotz A (1981) Risiko im Sport und anderswo. Neue Zürcher Zeitung 14 Feb: 37Google Scholar
  10. Lynn FM (1986) The interplay of science and values in assessing and regulating environmental risks. Sci Technol Hum Values 11: 40–50Google Scholar
  11. Ricci PF, Molton LS (1981) Risk and benefit in environmental law. Science 241: 1096–1100CrossRefGoogle Scholar
  12. Russell M (1986) Learning to manage risk: Res Manage July: 12–16Google Scholar
  13. Russell M, Gruber M (1987) Risk assessment in environmental policy-making. Science 236: 286–290PubMedCrossRefGoogle Scholar
  14. Schnitter N (1976) Statistische Sicherheit der Talsperren. Wasser, Energie, Lufteau, énergie, air 68: 126–129Google Scholar

Chemical Risks

  1. Anonymous (1987) Groundwater. Ciba-Geigy Corp, Toms River, New JerseyGoogle Scholar
  2. Anonymous (1987) The management of risk. Lancet 4 July: 54Google Scholar
  3. Blokker EF (1983) Erfahrungen bei der Durchführung von Risikoanalysen für einige Anlagen der petrochemischen Industrie in Rijnmond. In: Hartwig S (ed) Große technische Gefahrenpotentiale, Risikoanalysen und Sicherheitsfragen. Springer, Berlin Heidelberg New York, pp 161–170Google Scholar
  4. Drummond MF (1986) Economic aspects of risk assessment in chemical safety. Sci Total Environ 51: 81–124PubMedCrossRefGoogle Scholar
  5. Kenaga EE (1986) Assessing chemical hazards. Environ Sci Technol 20: 660–662CrossRefGoogle Scholar
  6. Mueke W (1987) Risikoabschätzung für Dioxine in der Umwelt. Chemosphere 16: 43–48CrossRefGoogle Scholar
  7. Pilz V (1980) Risikoermittlung und Sicherheitsanalysen in der chemischen Technik. Chem Ing Tech 52: 703–711CrossRefGoogle Scholar
  8. Pocchiari A et al. (1986) The chemical risk management process in Italy - a case study - the Seveso accident. Sci Total Environ 51: 227–235PubMedCrossRefGoogle Scholar
  9. Rice AP (1986) Risk management in chemical safety. Sci Total Environ 51: 1–17PubMedCrossRefGoogle Scholar
  10. Tarkowski S (1986) Data base for risk assessment. Sci Total Environ 51: 19–25PubMedCrossRefGoogle Scholar
  11. Todhunter JA (1986) Societal considerations in implementing risk management decisions. Sci Total Environ 51: 63–68PubMedCrossRefGoogle Scholar
  12. World Health Organization (1986) Risk management in chemical safety-conclusions and recommendations. Consultation between experts. Sci Total Environ 51: 261–263CrossRefGoogle Scholar
  13. Wilson R (1985) Direct testimony of Richard Wilson. Hearings for the U.S. CongressGoogle Scholar
  14. Young FE (1987) Risk assessment. Subcommittee on agriculture, U.S. House of Representatives 19 March: 18–21Google Scholar

Medical Risks

  1. Blum AL et al. (1987) The Lugano statements on controlled clinical trials. J Int Med Res 15: 2–22PubMedGoogle Scholar
  2. Charny MC, Farrow SC (1986) Risk targetting: approach to cost-containment. Health Policy 6: 1–10CrossRefGoogle Scholar
  3. Evers-Kiebooms G, Cassiman J-J, Van den Berghe H, D’Ydewalle G (eds) (1987) Genetic risk, risk perception, and decisionmaking. Liss, New YorkGoogle Scholar
  4. Herman JM (1984) Patients’ willingness to take risks in the management of pharyngitis. J Family Practice 19: 767–772Google Scholar
  5. Holzer JF (1984) Current concepts in risk management. Int Anesthesiol Clin 2: 92–116Google Scholar
  6. Mold JW, Stein HF (1986) The cascade effect in the clinical care of patients. N Engl J Med 20 Feb: 512–514CrossRefGoogle Scholar
  7. O’Brien B (1986) What are my chances, doctor? a review of clinical risks. Office of Health Education, LondonGoogle Scholar
  8. Pauker SG (1987) Decision analysis. N Engl J Med 316: 250–272PubMedCrossRefGoogle Scholar
  9. Pauker SG, Kassirer JP (1975) Therapeutic decision making: a cost-benefit analysis. N Engl J Med 293: 229–234PubMedCrossRefGoogle Scholar
  10. Pochin EE (1981) Quantification of risk in medical procedures. Proc R Soc Lond 376a: 87–101CrossRefGoogle Scholar
  11. Thompson MS (1986) Willingness to pay and accept risks to cure chronic disease. Am J Public Health 76: 392–396.PubMedCrossRefGoogle Scholar
  12. Weinstein MC, Fineberg HV (1980) Clinical decision analysis. Saunders, PhiladelphiaGoogle Scholar

Carcinogens

  1. Ames BN (1983) Dietary carcinogens and anticarcinogens. Science 221: 1256–1264PubMedCrossRefGoogle Scholar
  2. Ames BN (1984) Unser krebserregendes täglich Brot. Neue Zürcher Zeitung, Beilage Nr. 20: Forschung und Technik, Jan 25Google Scholar
  3. Ames BN et al. (1987) Ranking possible carcinogenic hazards. Science 236: 271–279PubMedCrossRefGoogle Scholar
  4. Fiering M, Wilson R (1983) Attempts to establish a risk by analogy. Risk Anal 3: 207–216CrossRefGoogle Scholar
  5. Gaffey WR (1985) Use of epidemiology in risk assessment. In: Li AP (ed) New approaches in toxicity testing and their application in human risk assessment. Raven, New York, pp 247–251Google Scholar
  6. Hattis DB (1986) The promise of molecular epidemiology for quantitative risk assessment. Risk Anal 6: 181–193PubMedCrossRefGoogle Scholar
  7. Milvy P (1986) A general guideline for management of risk from carcinogens. Risk Anal 6: 69–79PubMedCrossRefGoogle Scholar
  8. Montesano R, Tomatis L (1977) Legislation concerning chemical carcinogens in several industrialized countries. Cancer Res 37: 310–316PubMedGoogle Scholar
  9. Ryzin JV (1980) Quantitative risk assessment. J Occup Med 22: 321–326PubMedCrossRefGoogle Scholar
  10. Smith MV (1984) Use of risk assessment in regulatory decision-making. Food Technol Oct: 114–118Google Scholar

Adverse Drug Reactions

  1. Anonymous (1984) Measuring drug risk: Ciba Geigy’s monitoring. Scrip 951: 14–15Google Scholar
  2. Carson FL, Strom BL (1986) Techniques of postmarketing surveillance. Med Toxicol 1: 237–246PubMedGoogle Scholar
  3. Council for International Organizations of Medical Sciences (1986) Monitoring and assessment of adverse drug effects (working group report). CIOMS, GenevaGoogle Scholar
  4. Faich GA (1986) Adverse-drug-reaction monitoring. N Engl J Med 314: 1589–92PubMedCrossRefGoogle Scholar
  5. Gingell JC (1986) Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions - 2. Br Med J 292: 1190–91CrossRefGoogle Scholar
  6. Inman WHW (1984) Risks in medical intervention - balancing therapeutic risks and benefits. Pem News 2: 15–36Google Scholar
  7. Inman WHW (1985) Let’s get our act together. In: Dukes G (ed) Side effects of drugs annual 9. Elsevier, Amsterdam, pp XV-XXGoogle Scholar
  8. Karch FE, Lasagna L (1977) Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247–254PubMedGoogle Scholar
  9. Keown CF (1985) Contextual effects on people’s ratings of seriousness for side effects of prescription drugs. Percept Motor Skills 61: 435–441PubMedCrossRefGoogle Scholar
  10. Keown CF et al. (1984) Attitudes of physicians, pharmacists and laypersons toward seriousness and need for disclosure of prescription drug side effects. Health Psychol 3: 1–11PubMedCrossRefGoogle Scholar
  11. Mattison N (1984) Regulatory scene. Pharmaceut Med 1: 13–16Google Scholar
  12. McMahon FG (1983) How safe should drugs be? JAMA 249: 481–482PubMedCrossRefGoogle Scholar
  13. Napke E (1986) Adverse reactions: some pitfalls and postulates. Center for Study of Drug Development, BostonGoogle Scholar
  14. Shapiro S (1986) Risks of agranulocytosis and aplastic anemia - their relation to drug use with special reference to analgesics. JAMA 256: 1749–1757CrossRefGoogle Scholar
  15. Snell E (1987) How adverse are reactions to medicines? Scrip 1190: 22–23Google Scholar
  16. Tallarida RJ et al. (1984) Non-physicians and physicians assess severity of disease states and adverse drug reactions: application to drug benefit-risk measurement. Pharmaceut Med 1: 41–46Google Scholar
  17. Turner P (1984) Food and drugs: why different approaches to their safety? Lancet 19 May: 1116Google Scholar
  18. Vale JA, Meredith TJ (1986) Acute poisoning due to nonsteroidal anti-inflammatory drugs. Med Toxicol 1: 12–31PubMedGoogle Scholar
  19. Venning GR (1983) Identification of adverse reactions to new drugs I-IV. Br Med J 286: 199–202, 289–292, 365–368, 458–460, 544–547CrossRefGoogle Scholar
  20. Venulet J (1984) Functioning of the side effect surveillance system at Ciba-Geigy Basel. Industrie Santé Jan: 49Google Scholar
  21. Venulet J (1987) Informativity of adverse drug reactions data in medical publications. Center for Study of Drug Development (rs 8709), Tufts University, Boston (reprinted from Drug Inform J, 1985, 19: 357–365 )Google Scholar

Drug Risks

  1. Anonymous (1984) Measuring drug risk: Ciba-Geigy’s monitoring. Scrip 951: 14–15Google Scholar
  2. Anonymous (1987) ABPI issues post marketing surveillance guidelines. Market Lett 7 Nov: 13Google Scholar
  3. Anonymous (1987) Intrauterine devices maker gambles on the informed consumer. Washington Post 13 MarchGoogle Scholar
  4. Anonymous (1987) RAD-AR program analyzes risk for Ciba-Geigy. Market Lett 21 Sept: 25Google Scholar
  5. Anonymous (1987) Risk management meeting: conference report, Brighton. Br Med J 294: 1678–79CrossRefGoogle Scholar
  6. Azaraoff DL, Herting RL (1984) Drug development: risks and problems. Ann NY Acad Sci 432: 279–285CrossRefGoogle Scholar
  7. Borda IT, Bernecker GC (1985) The pharmaceutical industry - drug monitoring by Ciba-Geigy. In: Inman WHW (ed) Monitoring for drug safety. MTP Press Boston, pp 173–200Google Scholar
  8. BPI (ed) (1985) Drugs - potential and risks. BPI, Frankfurt/MainGoogle Scholar
  9. Brown P (1987) Ciba-Geigy’s risk assessment. Scrip 1227: 15Google Scholar
  10. Carroll NV et al. (1986) Perceived risks and pharmacists’ generic substitution behavior. J Consumer Aff 20: 36–47CrossRefGoogle Scholar
  11. Chetley A, Gilbert A (1986) Problem drugs - introduction. HAI, The Hague, pp 1–4Google Scholar
  12. Council for International Organizations of Medical Sciences (1986) Monitoring and assessment of adverse drug effects (working group report). CIOMS, GenevaGoogle Scholar
  13. Destevens G (1987) The risks and benefits of drug therapy. Med Res Rev 7: 173–181PubMedCrossRefGoogle Scholar
  14. Diamond LD, Laurence DR (1985) Product liability in respect of drugs. Br Med J 290: 365–368CrossRefGoogle Scholar
  15. Faich GA (1986) Analgetic risks and pharmacoepidemiology. JAMA 256 13: 1788Google Scholar
  16. Haire D (1984) How the FDA determines the “safety” of drugs. National Women’s Health Network, Washington D.C.Google Scholar
  17. Hallett C, Dean BC (1984) Bromazepam: acute benefit-risk assessment in general practice. Curr Med Res Opinion 8: 683–688CrossRefGoogle Scholar
  18. Heilmann K (1986) Impact of professional and lay media on patients and physicians. Am J Med 80 [Suppl 6 a]: 5–7CrossRefGoogle Scholar
  19. Inman WHW (1984) Risks in medical intervention - balancing therapeutic risks and benefits. Pem News 2: 15–36Google Scholar
  20. Inman WHW (1985) Let’s get our act together. In: Dukes G (ed) Side effects of drugs annual 9. Elsevier, Amsterdam, pp XV-XXGoogle Scholar
  21. Inman WHW (1987) Requirements for risk-benefit assessment of drugs before withdrawal. Pem News [Suppl] March: 4Google Scholar
  22. Inman WHW (1987) Prescription-event monitoring. Its strategic role in post marketing surveillance for drug safety. Pem News 4: 16–29Google Scholar
  23. Keown CF (1985) Contextual effects on people’s ratings of seriousness for side effects of prescription drugs. Percept Motor Skills 61: 435–441PubMedCrossRefGoogle Scholar
  24. Keown CF, Slovic P, Lichtenstein S (1984) Influence of information about side effects on perceived risk of prescription drugs. In: Winston WJ (ed) Marketing for mental health services. Haworth Press, pp 111–123Google Scholar
  25. Keown CF et al. (1984) Attitudes of physicians, pharmacists and laypersons toward seriousness and need for disclosure of prescription drug side effects. Health Psychol 3: 1–11PubMedCrossRefGoogle Scholar
  26. Lane DA, Hutchinson TA (1987) The notion of acceptable risk: the role of utility in drug management. J Chronic Dis 40: 621–625PubMedCrossRefGoogle Scholar
  27. Lasagna L (1987) Postmarketing surveillance of multisource drugs - report of a conference, 9-10 July 1986. Center for the Study of Drug Development, Tufts University ps 8711: 1–58Google Scholar
  28. Laurence DR, Black JW (1978) The medicine you take. Croom Helm, LondonGoogle Scholar
  29. McMahon FG (1983) How safe should drugs be? JAMA 249: 481–482PubMedCrossRefGoogle Scholar
  30. Pedroni G (1982) Drugs and adverse reactions. Pharma Information, BasleGoogle Scholar
  31. Richard BW (1987) Drug regulation in the United States and the United Kingdom: the depo-prover story. Ann Intern Med 106: 886–891PubMedGoogle Scholar
  32. Shapiro S (1986) Risks of agranulocytosis and aplastic anemia - their relation to drug use with special reference to analgesics. JAMA 256: 1749–1757CrossRefGoogle Scholar
  33. Snell E (1987) How adverse are reactions to medicines? Scrip 1190: 22–23Google Scholar
  34. Spitzer WO, Hutchinson T, Lane D (1987) Postmarketing management of drug use: toward rational public policy. Can Med Assoc J 136: 1022–1024Google Scholar
  35. Spivey RN, Lasagna L, Trimble AG (1987) New indication for already-approved drugs: time trends for the new drug application review phase. Clin Pharmacol Ther 41: 368–370PubMedCrossRefGoogle Scholar
  36. Turner P (1984) Food and drugs: why different approaches to their safety? Lancet 19 May: 1116Google Scholar
  37. Ueberla K (1984) Sicherheit und Risiko im Arzneimittelbereich - Fiktion und Realität. In: Lange S (ed) Ermittlung und Bewertung industrieller Risiken. Springer, Berlin Heidelberg New YorkGoogle Scholar
  38. Urquhart J, Heilmann K (1985) Drugs: risk vs benefit. Edition Agrippa, CologneGoogle Scholar
  39. Vance MA, Millington WR (1986) Principles of irrational drug therapy. Int J Health Serv 16: 355–362PubMedCrossRefGoogle Scholar
  40. Venning GRI(1984) Priorities in the benefit-risk assessment of new drug. Adverse Drug React Acute Poisoning Rev 3: 113–21PubMedGoogle Scholar
  41. Volans GN (1987) Monitoring the safety of over the counter drugs. Br Med J 295: 797–798CrossRefGoogle Scholar
  42. von Wartburg WP (1985) Ten aspects of risk as applied to pharmaceuticals. Ciba-Geigy J 2Google Scholar
  43. Walker SR, Gelzer J et al. (1986) A comparative retrospective analysis of data for short- and long- term animal toxicity studies on 40 pharmaceutical compounds. Center for Study of Drug Development, BostonGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Bruno Horisberger
    • 1
  • Rolf Dinkel
    • 2
  1. 1.Interdisciplinary Research Centre for Public HealthSt. GallenSwitzerland
  2. 2.HealthEcon Ltd.BaselSwitzerland

Personalised recommendations